
Stem Cells Speed Up Alzheimer’s Research
VIDEO+ARTICLE A cutting-edge lab in Cambridge is using human brain cells made in the lab to test experimental Alzheimer’s drugs. See how the use of

VIDEO+ARTICLE A cutting-edge lab in Cambridge is using human brain cells made in the lab to test experimental Alzheimer’s drugs. See how the use of

If you live with Alzheimer’s, the need for more research funds may be obvious to you, but not so obvious to the government. The Alzheimer’s

VIDEO+ARTICLE Cognoptix announced strong results in a clinical trial of its SAPPHIRE II eye test. It successfully identified Alzheimer’s via the human eye’s beta-amyloid signature.

VIDEO Watch this proud stand from the Colorado Senate. See a truly moving tribute to people with Alzheimer’s, as well as caretakers and the many
VIDEO+ARTICLE Simple eye tests have the potential to transform the way Alzheimer’s is detected and managed. Find out how two quick, low-cost Alzheimer’s eye tests

VIDEO+ARTICLE See the most successful basketball coach in history discuss her life since leaving the court to battle dementia. Find out about her new position
VIDEO Music legend Glen Campbell hasn’t let his battle with Alzheimer’s keep him from his music. His wife, Kim, tells USA TODAY about his life

VIDEO + ARTICLE Doctors think many Alzheimer’s drug trials fail because it is too late to cure the disease by the time people notice it.

Turbocharging the popular Alzheimer’s drug called Namenda with nitroglycerin achieved a better level of treatment in the lab. Learn how the new formulation, called NitroMemantine,

Massive amounts of data have been generated by the first “Big Data” global project for Alzheimer’s disease, called the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Discover

INNOVATION – VIDEO: A big supermarket launched a ‘relaxed’ checkout lane to make life a little less stressful for people with dementia and other vulnerable people.

VIDEO + ARTICLE: Residential areas with more green space were associated with faster thinking, better attention, and higher overall cognitive function in a federal study. Learn more.

Lecanemab is today’s #1 Alzheimer’s antibody. (Brand name: Leqembi) Washington University researchers found Lecanemab’s adverse events to be rare and manageable in very mild or mild Alzheimer’s.

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?

An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?

Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!

It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.



We use cookies and similar technologies to improve your experience, understand how our content is used, and support relevant advertising that helps keep Alzheimer’s Weekly free to readers. You can choose to accept, deny, or manage your preferences at any time. Declining certain cookies may affect features such as embedded videos, comments, and personalized advertising.